Phare Bio
Business Services · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.pharebio.orgRevenue
<$5 MillionIndustry
About Phare Bio
Phare Bio is a social venture focused on utilizing generative AI and deep learning to discover new classes of antibiotics in response to the global antimicrobial resistance crisis. The company collaborates with the Collins Lab at MIT to develop AIBiotics, the world's first generative AI antibiotics discovery engine, aimed at addressing urgent threats posed by antibiotic-resistant bacteria. Phare Bio's unique business model combines donor funding for preclinical development with strategic partnerships for clinical trials, ensuring that novel antibiotic therapies reach those in greatest need. Backed by significant grants from organizations like TED's Audacious Project and Google.org, Phare Bio is committed to unlocking social impact through innovative healthcare solutions.Explore more
Phare Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Phare Bio
Compare insights from companies similar to Phare Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Phare Bio Tech Stack
A closer look at the technologies used by Phare Bio
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Phare Bio
Sign Up For FreeTo access detailed company insights
Phare Bio is a social venture focused on utilizing generative AI and deep learning to discover new classes of antibiotics in response to the global antimicrobial resistance crisis. The company collaborates with the Collins Lab at MIT to develop AIBiotics, the world's first generative AI antibiotics discovery engine, aimed at addressing urgent threa... Read More
